NEW MJ NEWS

AbbVie to Host Fourth-Quarter 2022 Earnings Conference Call

AbbVie (NYSE: ABBV) will announce its fourth-quarter 2022 financial results on Thursday, February 9, 2023, before the market opens. AbbVie will host a live webcast of the earnings conference call at 8 a.m. CT. It will be accessible through AbbVie’s Investor Relations website investors.abbvie.com. An archived edition of the session will be available later that day.

About AbbVie

AbbVie’s mission is to discover and deliver innovative medicines that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people’s lives across several key therapeutic areas: immunology, oncology, neuroscience, eye care, virology and gastroenterology, in addition to products and services across its Allergan Aesthetics portfolio. For more information about AbbVie, please visit us at www.abbvie.com. Follow @abbvie on Twitter, Facebook, Instagram, YouTube and LinkedIn.

View original content to download multimedia:https://www.prnewswire.com/news-releases/abbvie-to-host-fourth-quarter-2022-earnings-conference-call-301711231.html

SOURCE AbbVie


MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

$XXII Purchases Important Intellectual Property and Announces Hiring of 10 New Employees

22nd Century Acquires Important Intellectual Property from the National Research Council of…

1933 Industries Inc. (TGIF.CN) (TGIFF) Product Collaboration Between Birdhouse Skateboards™ and Canna Hemp X™

1933 Industries’ Product Collaboration Between Birdhouse Skateboards™ and Canna Hemp X™ set…

 Rocky Mountain High Brands, Inc. (RMHB) Announces Third Shipment to Their New York City Distribution Partners

Rocky Mountain High Brands Announces Third Shipment to Their New York City…

Namaste Technologies Inc. (NXTTF) Announces Definitive Agreement to Commercialize Needle-Free Injector Technology

Namaste Announces Definitive Agreement to Commercialize Needle-Free Injector Technology for Medical Cannabis…